Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sibilia

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Cancer Cell|August 4, 2009
Raf-1 addiction in Ras-induced skin carcinogenesisKarin Ehrenreiter, Florian Kern, Vanishree Velamoor, et al.
Development (Cambridge, England)|August 20, 2003
Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
Cells|November 26, 2022
Inactivation of Autophagy in Keratinocytes Reduces Tumor Growth in Mouse Models of Epithelial Skin CancerCaterina Barresi, Heidemarie Rossiter, Maria Buchberger, et al.
The Journal of Clinical Investigation|January 19, 2012
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cellsBarbara Drobits, Martin Holcmann, Nicole Amberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Skin inflammation is not sufficient to break tolerance induced against a novel antigenMartin Holcmann, Patrizia Stoitzner, Barbara Drobits, et al.
Developmental Cell|June 7, 2003
c-Jun regulates eyelid closure and skin tumor development through EGFR signalingRainer Zenz, Harald Scheuch, Paul Martin, et al.
The EMBO Journal|April 3, 2002
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liverAxel Behrens, Maria Sibilia, Jean-Pierre David, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
Psoriasis-like disease prevents squamous skin tumor development by neutrophil-driven inflammationPanagiota Tsokkou, Martin Holcmann, Katharina Rindler, et al.
Elife|June 3, 2020
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasisTheresa Benezeder, Clemens Painsi, VijayKumar Patra, et al.
The FEBS Journal|August 25, 2017
Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasisMaria Kral, Christoph Klimek, Betül Kutay, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Cancer Cell|August 4, 2009
Raf-1 addiction in Ras-induced skin carcinogenesisKarin Ehrenreiter, Florian Kern, Vanishree Velamoor, et al.
Development (Cambridge, England)|August 20, 2003
Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heartMaria Sibilia, Bettina Wagner, Astrid Hoebertz, et al.
Cells|November 26, 2022
Inactivation of Autophagy in Keratinocytes Reduces Tumor Growth in Mouse Models of Epithelial Skin CancerCaterina Barresi, Heidemarie Rossiter, Maria Buchberger, et al.
The Journal of Clinical Investigation|January 19, 2012
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cellsBarbara Drobits, Martin Holcmann, Nicole Amberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2009
Skin inflammation is not sufficient to break tolerance induced against a novel antigenMartin Holcmann, Patrizia Stoitzner, Barbara Drobits, et al.
Developmental Cell|June 7, 2003
c-Jun regulates eyelid closure and skin tumor development through EGFR signalingRainer Zenz, Harald Scheuch, Paul Martin, et al.
The EMBO Journal|April 3, 2002
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liverAxel Behrens, Maria Sibilia, Jean-Pierre David, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
Psoriasis-like disease prevents squamous skin tumor development by neutrophil-driven inflammationPanagiota Tsokkou, Martin Holcmann, Katharina Rindler, et al.
Elife|June 3, 2020
Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasisTheresa Benezeder, Clemens Painsi, VijayKumar Patra, et al.
The FEBS Journal|August 25, 2017
Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasisMaria Kral, Christoph Klimek, Betül Kutay, et al.
Pageof 12